OrbiMed et al Fund Pharma Ingredients Development
18 Dec 2023
US$ 19.00
OrbiMed Advisors LLC has led the series B financing round undertaken by Hunan Norchem Pharmaceutical Co Ltd (Norchem)....
Related Publications
Subscribers’ Weekly for the week ending 25 July 2025...
Listen to Subscribers' Weekly 25 Jul 2025...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.